Concise guidance: diagnosis and management of polymyalgia rheumatica.
Polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription with great heterogeneity in presentation, response to steroids and disease course. The British Society for Rheumatology and the British Health Professionals in Rheumatology have recently published guidelines on management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines and provide a safe and specific diagnostic process with advice on management and monitoring--specifically targeted at general practitioners, general physicians and rheumatologists.
Bhaskar
Dasgupta
D
Department of Rheumatology, Essex University Southend University Hospital, Westcliff-on-Sea, Essex. bhaskar.dasgupta@southend.nhs.uk
D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage; D011111:Polymyalgia Rheumatica / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage; D012017:Referral and Consultation
D005938:Glucocorticoids; D011239:Prednisolone; D008775:Methylprednisolone